Project Grant R21AI188152
Award Date
1/17/25
Completion Date
12/31/26
Dollars Obligated
$219K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This National Institute of Allergy and Infectious Diseases (NIAID) Project Grant award of $204,347 supports research on decoding the host-pathogen interactions that enable the intracellular colonization of human cells by the foodborne pathogen Salmonella enterica. The project, which runs from November 2024 to October 2026, will use advanced techniques like fluorescence-assisted cell sorting and dual RNA sequencing to characterize the bacterial and host factors that drive the formation of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $206,251 to Duke University to investigate the molecular mechanisms and pathophysiology of Salmonella Typhimurium infection. The research aims to elucidate how the bacterial effector protein SARA manipulates the host STAT3 signaling pathway to promote anti-inflammatory responses and enhance the pathogen's...
The University of Utah was awarded a $728,244 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, titled "Salmonella Type III Secretion: Substrate Targeting and Injectisome Assembly," aims to provide fundamental knowledge about the mechanisms controlling the assembly and function of injectisomes - large multi-protein molecular machines used by many human pathogens,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $225,839 Project Grant (Award ID: R21AI187632) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis. The grant, which runs from Sep 26, 2024 to Aug 31, 2026, will fund research to investigate whether interleukin-18 receptor (IL-18R) expression enables non-cognate responsiveness and robust tissue-resident memory (TRM) CD4 T cell-mediated protection against...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at Stanford University aimed at understanding how typhoidal Salmonella serovars interact with and manipulate human macrophages. The $1,447,515 award, effective from July 3, 2024 to May 31, 2029, employs unbiased methodologies such as random barcode transposon-site sequencing, genomic...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $531,245 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The project, entitled "Structure and Function of the Salmonella Type III Secretion Sorting Platform", focuses on the structural and functional characterization of the sorting platform, a critical component of the Type III Secretion System found in many pathogenic bacteria. Using a...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,725 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Iowa to investigate the use of an engineered probiotic E. coli strain to reduce Salmonella carriage in poultry. The two-year project, running from July 2024 to May 2026, aims to optimize the binding activity of the E. coli strain's type 1 fimbriae and demonstrate its ability to competitively exclude Salmonella from...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $1,584,217 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Dana-Farber Cancer Institute, Inc. (DFCI) to develop and apply a high-throughput single-cell RNA sequencing platform called PROBAC-SEQ to profile the transcriptional states of individual Salmonella enterica bacterial cells during infection. The grant aims to create an atlas of Salmonella transcriptional cell states, infer how...
This $844,975 federal Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research by Northwestern University on how the bacterial pathogen Salmonella Typhimurium makes rapid, accurate decisions to survive when engulfed by immune cells. Using advanced microfluidics and live-cell imaging techniques, the project investigates how Salmonella leverages contextual cues to activate virulence genes and adapt to the hostile phagosome...
This $126,096 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research at the University of California, San Diego (UCSD) to elucidate the mechanisms of microbial competition between Salmonella Typhimurium (STM) and the gut microbiome. The research employs advanced sequencing techniques like metatranscriptomics and metatranslatomics to profile microbial metabolism and...